Armata Pharmaceuticals Announces Appointment of Experienced Accounting and Finance Professional David House as Senior Vice President of Finance and Chief Financial Officer
LOS ANGELES, 15 August 2024 /PRNewswire/ — Armata Pharmaceuticals, Inc. (NYSE American: ARMP) (“Armata” or the “Pursue“), a biotechnology company focused on developing highly purified, pathogen-specific bacteriophage therapeutics for antibiotic-resistant and difficult-to-treat bacterial infections, today announced the appointment of an experienced life sciences accounting and finance professional David House as Senior Vice President, Finance, effective […]